Skip to content
Open Data Finder
Socrata networkLive preview

SARS-CoV-2 Molecular Sequencing Results – Clinical Specimen and Wastewater Samples

Published by City of Chicago

About this dataset

The SARS-CoV-2 virus, or the virus that causes COVID-19, has mutated numerous times since it was first recognized in humans at the start of the COVID-19 pandemic. These mutations, if distinct enough, can result in new types of SARS-CoV-2, which are called different “lineages” of the virus. Depending on the types of genetic mutations involved, SARS-CoV-2 lineages can vary widely in their ability to cause severe disease, transmit between people, or escape the protective effects of vaccination. During high levels of COVID-19 in the community, multiple lineages of the virus can be circulating at once. In other words, different Chicagoans can both be sick with COVID-19, but due to infection with different lineages. For this reason, it is important to understand generally which lineages of SARS-CoV-2 are circulating in Chicago and infecting residents. With a better understanding of more or less prevalent lineages, the Chicago Department of Public Health (CDPH) can help advise healthcare providers and residents about the best ways to take protective action. This dataset includes genetic sequencing results from both clinical laboratory specimens and wastewater samples. Results from these datasets—and a description of each—are currently published in separate datasets: wastewater and laboratory . Briefly: - Wastewater samples are collected from across multiple city sites twice weekly year-round. These samples are tested for the concentration of SARS-CoV-2 virus and then are genetically sequencing to determine which virus lineages are present and in what relative amount. Because wastewater is always collected each week, genetic sequencing results for wastewater data are available weekly. - Clinical laboratory samples represent positive SARS-CoV-2 PCR tests voluntarily reported by network of several hospital laboratories in Chicago as well as two commercial laboratories serving Chicago facilities. These data do not include patient demographic nor geographic information and represent both Chicago and non-Chicago residents tested by the reporting facility. Because sample submission volume varies throughout the year and can be very low when community-levels of COVID-19 are low, genetic sequencing results are aggregated to the monthly level. For each set, the “lineage percent” is provided for all detected lineages, which reflects the relative amount of the lineage detected across all samples collected during that time period (as a percent of all lineages detected). Results for both datasets are aligned to the Saturday ending each week; because of the different aggregation timelines, results should be interpreted as follows: - Wastewater data reflect the relative proportion of all lineages detected that week in wastewater. - Clinical data reflect the relative proportion of all lineages detected over the past four weeks across all clinical samples.

Live preview

The first rows, fetched from Socrata network when you open this page.

Loading the first rows from the source…

SARS-CoV-2 Molecular Sequencing Results – Clinical Specimen and Wastewater Samples · Open Data Finder